Dinh, J. C., Boone, E. C., Staggs, V. S., Pearce, R. E., Wang, W. Y., Gaedigk, R., . . . Gaedigk, A. (2022). The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity. Clinical pharmacology and therapeutics, 111(3), 646. https://doi.org/10.1002/cpt.2469
Chicago-Zitierstil (17. Ausg.)Dinh, Jean C., Erin C. Boone, Vincent S. Staggs, Robin E. Pearce, Wendy Y. Wang, Roger Gaedigk, James Steven Leeder, und Andrea Gaedigk. "The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity." Clinical Pharmacology and Therapeutics 111, no. 3 (2022): 646. https://doi.org/10.1002/cpt.2469.
MLA-Zitierstil (9. Ausg.)Dinh, Jean C., et al. "The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity." Clinical Pharmacology and Therapeutics, vol. 111, no. 3, 2022, p. 646, https://doi.org/10.1002/cpt.2469.